Cadrenal Therapeutics, Inc. SEC filings CVKD
Cadrenal Therapeutics, Inc. has 277 filings in SEC EDGAR's recent list, going back to Jul 15, 2022. Its latest annual report, Form ARS, was filed on Aug 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 7, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 20, 2026 | — |
| D | Filing | Jul 15, 2026 | — |
| EFFECT | Filing | Apr 29, 2026 | — |
| CORRESP | Letter to the SEC | Apr 27, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2026 | — |
| D | Filing | Apr 6, 2026 | — |
| EFFECT | Filing | Dec 31, 2025 | — |
| D | Filing | Dec 31, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 31, 2025 | — |
| CORRESP | Letter to the SEC | Dec 30, 2025 | — |
| EFFECT | Filing | Nov 22, 2024 | — |
| CORRESP | Letter to the SEC | Nov 21, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2024 | — |
| D | Filing | Nov 14, 2024 | — |
| EFFECT | Filing | Apr 2, 2024 | — |
| EFFECT | Filing | Mar 20, 2024 | — |
| CORRESP | Letter to the SEC | Mar 18, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2024 | — |
| EFFECT | Filing | Jul 28, 2023 | — |
| CORRESP | Letter to the SEC | Jul 26, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 26, 2023 | — |
| D | Filing | Jul 18, 2023 | — |
| SEC STAFF LETTER | Filing | Jan 20, 2023 | — |
| CERT | Filing | Jan 20, 2023 | — |
| EFFECT | Filing | Jan 19, 2023 | — |
| 8-A12B | Registration of certain classes of securities | Jan 17, 2023 | — |
| CORRESP | Letter to the SEC | Jan 17, 2023 | — |
| CORRESP | Letter to the SEC | Jan 17, 2023 | — |
| CORRESP | Letter to the SEC | Dec 8, 2022 | — |
| D | Filing | Dec 8, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 8, 2022 | — |
| CORRESP | Letter to the SEC | Oct 17, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2022 | — |
| SEC STAFF LETTER | Filing | Oct 12, 2022 | — |
| CORRESP | Letter to the SEC | Sep 22, 2022 | — |
| DRSLTR | Filing | Sep 2, 2022 | — |
| DRS/A | Filing | Sep 2, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2022 | — |
| DRSLTR | Filing | Aug 23, 2022 | — |
| DRS/A | Filing | Aug 23, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 11, 2022 | — |
| D | Filing | Jul 25, 2022 | — |
| DRS | Filing | Jul 15, 2022 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CVKD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Ponte Vedra, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1937993
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.